HLscience Co. Ltd (239610) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.023x

Based on the latest financial reports, HLscience Co. Ltd (239610) has a cash flow conversion efficiency ratio of -0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.01 Billion ≈ $-1.36 Million USD) by net assets (₩87.36 Billion ≈ $59.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HLscience Co. Ltd balance sheet independence to measure how much of total assets are equity-financed.

HLscience Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how HLscience Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 239610 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

HLscience Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HLscience Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sun Summit Minerals Corp V:SMN	-0.490x
DATRIX S.P.A. F:BW6	N/A
GeneMatrix Inc KQ:109820	0.027x
Helport AI Limited Ordinary Shares NASDAQ:HPAI	N/A
GUH Holdings Bhd KLSE:3247	-0.033x
RENDER CUBE BSAC ZY -10 F:W63	N/A
CT AUTOMOTIVE GROUP -005 F:X7X	N/A
Telefast Indonesia JK:TFAS	0.023x

Annual Cash Flow Conversion Efficiency for HLscience Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of HLscience Co. Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of HLscience Co. Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩94.54 Billion ≈ $64.07 Million	₩-3.59 Billion ≈ $-2.43 Million	-0.038x	-99.23%
2023-12-31	₩102.59 Billion ≈ $69.53 Million	₩-1.96 Billion ≈ $-1.33 Million	-0.019x	-150.22%
2022-12-31	₩104.22 Billion ≈ $70.63 Million	₩3.95 Billion ≈ $2.68 Million	0.038x	-61.45%
2021-12-31	₩107.26 Billion ≈ $72.69 Million	₩10.56 Billion ≈ $7.16 Million	0.098x	-36.97%
2020-12-31	₩95.84 Billion ≈ $64.95 Million	₩14.97 Billion ≈ $10.14 Million	0.156x	-40.67%
2019-12-31	₩81.21 Billion ≈ $55.04 Million	₩21.38 Billion ≈ $14.49 Million	0.263x	+27.35%
2018-12-31	₩62.99 Billion ≈ $42.69 Million	₩13.02 Billion ≈ $8.82 Million	0.207x	+88.26%
2017-12-31	₩53.14 Billion ≈ $36.01 Million	₩5.83 Billion ≈ $3.95 Million	0.110x	-0.29%
2016-12-31	₩50.19 Billion ≈ $34.01 Million	₩5.53 Billion ≈ $3.75 Million	0.110x	-48.47%
2015-12-31	₩14.53 Billion ≈ $9.85 Million	₩3.10 Billion ≈ $2.10 Million	0.214x	-5.19%
2014-12-31	₩10.26 Billion ≈ $6.95 Million	₩2.31 Billion ≈ $1.57 Million	0.225x	--

About HLscience Co. Ltd

KQ:239610 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$18.26 Million

₩26.94 Billion KRW

Market Cap Rank

#25361 Global

#1854 in Korea

Share Price

₩5290.00

Change (1 day)

+0.19%

52-Week Range

₩5090.00 - ₩11910.00

All Time High

₩105342.87